| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Shanler Stuart | Chief Scientific Officer | Feb 01, 2019 | Option Exercise | $6.96 | 1,308 | 9,104 | 272,047 | Feb 05, 2019, 06:32 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Shanler Stuart | Chief Scientific Officer | Dec 18, 2018 | Option Exercise | $6.30 | 412 | 2,596 | 269,480 | Dec 21, 2018, 07:32 AM | |
| ACRS | Aclaris Therapeutics, Inc. | Shanler Stuart | Chief Scientific Officer | Dec 15, 2018 | Option Exercise | $7.31 | 370 | 2,705 | 268,442 | Dec 18, 2018, 08:53 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Shanler Stuart | Chief Scientific Officer | May 07, 2018 | Option Exercise | $18.10 | 1,480 | 26,788 | 267,512 | May 09, 2018, 04:21 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Shanler Stuart | Chief Scientific Officer | Dec 18, 2017 | Option Exercise | $24.12 | 441 | 10,637 | 263,792 | Dec 21, 2017, 04:55 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Shanler Stuart | Chief Scientific Officer | Dec 15, 2017 | Option Exercise | $24.23 | 395 | 9,571 | 262,783 | Dec 21, 2017, 04:55 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Shanler Stuart | Chief Scientific Officer | Dec 18, 2016 | Option Exercise | $31.25 | 441 | 13,781 | 261,878 | Dec 20, 2016, 06:49 PM |
Menu